H2-Ab1 deficiency in macrophages ameliorates spinal cord injury by regulating phagocytosis processing

When the spinal cord is injured, the body's immune system launches a complex and often chaotic response. Among the key players in this response are macrophages, a type of white blood cell that acts as a cellular cleanup crew. Their job is to clear away dead tissue and debris left behind by the trauma. However, in the confined space of the spinal cord, this cleanup can sometimes go too far. When these cells consume too much debris, they can become overloaded and transform into "foamy" cells that release harmful inflammatory chemicals. This excessive inflammation damages healthy nerve cells and prevents the spinal cord from healing. Scientists have long known that controlling this cleanup process is vital for recovery, but they have been searching for the specific molecular switch that tells these cells when to stop and when to start causing trouble.

A recent study from researchers at the Third Affiliated Hospital of Sun Yat-sen University has identified one such switch. The team focused on a specific gene called H2-Ab1, which is part of a larger system known as the Major Histocompatibility Complex Class II. In simple terms, this system helps cells recognize what belongs in the body and what does not. The researchers wanted to understand exactly where this gene is active after a spinal cord injury and what happens if it is turned off. By using a combination of genetic engineering and detailed observation in mice, they discovered that this gene is primarily active in the macrophages that travel into the injury site from the blood, rather than in the resident immune cells that live permanently in the brain and spinal cord. More importantly, they found that turning off this gene in those traveling macrophages stops the cells from becoming overloaded, reduces harmful inflammation, and allows the spinal cord to heal much better.

To find the location of this gene's activity, the researchers first looked at the genetic activity in injured spinal cords at different times after the injury. They found that the H2-Ab1 gene became very active, peaking about seven days after the injury. This timing coincided with the arrival of a large number of immune cells. However, a challenge remained: the spinal cord contains two types of immune cells that look very similar. One type, called microglia, lives inside the spinal cord from birth. The other type, macrophages, enters the area from the bloodstream after an injury. Both can express the H2-Ab1 gene, making it difficult to tell which one was driving the damage. To solve this, the scientists bred special mice where they could light up one cell type with a red glow while leaving the other dark. When they examined the injured spinal cords, they saw that the red glow of the H2-Ab1 gene was overwhelmingly present in the cells that had traveled in from the blood, not the ones that lived there originally. This confirmed that the problem was specifically with the invading macrophages.

The team then tested what would happen if they could turn off this gene in just those invading cells. They created two groups of mice: one group where the gene was disabled in the invading macrophages, and another where it was disabled in the resident microglia. When these mice suffered a spinal cord injury, the results were striking. The mice with the gene turned off in their invading macrophages showed significantly better recovery. They could move their hind legs more effectively, walked with a steadier gait, and had stronger electrical signals traveling from their brain to their legs compared to the control mice. In contrast, turning off the gene in the resident microglia made no difference to the outcome. This proved that the invading macrophages were the critical factor, and that their behavior was being driven by the H2-Ab1 gene.

Digging deeper into the cellular level, the researchers discovered why this gene caused such trouble. In the mice where the gene was active, the invading macrophages were seen swallowing massive amounts of debris, including fragments of the protective coating around nerves and fat droplets. This overeating turned them into the "foamy" cells that release toxic chemicals. These chemicals created a storm of reactive oxygen species, which are unstable molecules that damage and kill nearby nerve cells. However, in the mice where the gene was turned off, the macrophages did not become foamy. They ate less debris, released far fewer toxic chemicals, and did not produce the same level of reactive oxygen species. As a result, the nerve cells in the injured area survived in much greater numbers, and the scar tissue that usually blocks healing was smaller and less dense.

The study also looked at how these cells changed their behavior. Normally, when macrophages become foamy, they switch to a mode that promotes inflammation and tissue destruction. The researchers found that when the H2-Ab1 gene was present, the cells were full of markers for this destructive mode. But when the gene was removed, the cells shifted toward a calmer, healing mode that helps repair tissue. This shift meant that the environment around the injury became less hostile, allowing the spinal cord to begin the slow process of repair. The researchers confirmed these findings in the lab by growing cells in dishes and treating them with the same genetic changes, observing the same reduction in harmful chemicals and cell death.

This work provides a clear picture of a specific mechanism that worsens spinal cord injuries. It shows that the body's own cleanup crew can become a liability if it is not properly regulated, and that a single gene in the invading cells can dictate whether that cleanup helps or harms. By identifying H2-Ab1 as the driver of this harmful process, the study points to a potential new target for treatment. If doctors could one day block this gene specifically in the immune cells that enter the spinal cord after an injury, they might be able to stop the cycle of inflammation and cell death, giving patients a much better chance of recovering movement and function. The findings suggest that the key to healing may not be stopping the immune system entirely, but rather fine-tuning its behavior to prevent it from causing more damage than the injury itself.